PhysIQ: physIQ, InCardia Therapeutics Partner on Phase III Afib Study
The trial design incorporates wearable sensors, FDA-cleared biomarkers, and near real-time data to screen, enroll, and track patients more quickly.
Read full article »
PhysIQ develops an AI-based platform that offers physiology data analytics solutions to the healthcare sector.
Read more